DOI . ORG {}

Matching Content Categories {📚}

• Science
• Health & Fitness
• Education

Content Management System {📝}

What CMS is doi.org built with?

Custom-built

No common CMS systems were detected on Doi.org, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of doi.org audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Doi.org Make Money? {💸}

The income method remains a mystery to us.

Not every website is profit-driven; some are created to spread information or serve as an online presence. Websites can be made for many reasons. This could be one of them. Doi.org might be cashing in, but we can't detect the method they're using.

Keywords {🔍}

irs, cancer, cells, breast, erα, growth, cell, protein, signaling, mcf, fig, receptor, expression, proteins, data, article, insulin, overnight, treatment, levels, google, scholar, igfi, cas, treated, determined, induced, degradation, lines, cyclin, yee, results, immunoblotting, total, sirna, starved, insulinlike, igfir, effects, proliferation, actin, panels, serumstarved, panel, serine, phosphorylation, resulted, downregulation, monolayer, tamr,

Topics {✒️}

horseradish peroxidase-conjugated anti-phosphotyrosine disrupt igf-ir/ir-irs-1-erα complex irs-1-igf-ir/inr complex resulting endocrine-resistant breast cancer irs-1-igf-ir/inr/erα complex hormone-resistant tamr cancers mcf-7l tamoxifen-resistant independent triplicates experiments estrogen receptor-α-positive anti-igf-ir-targeted therapies igf-i-stimulated cyclin d1 viola-villegas nt igf-ir monoclonal antibody erα-negative breast cancers irs-igf-ir/inr complex er-positive breast cancers anchorage-independent growth assays ligand-induced erα phosphorylation affect short-term igf transit-siquest transfection reagent masonic cancer center erα + breast cancer cells treatment-induced signaling transduction jie ying chan estrogen receptor alpha insulin receptor substrate insulin receptor substrate-1 insulin receptor substrate-2 nt157 inhibited igf-ir mapk-dependent serine phosphorylation growth factor-mediated signaling small-molecule tyrphostin targeting obesity-induced insulin resistance mediate igf/insulin signaling estrogen-depleted growth media estrogen receptor-positive propidium iodide-stained nuclei igf-i-treated conditions targeting igf-ir axis insulin receptor substrates erα-regulated gene expression erα+ cell lines human breast cancer dose-response curves showed related subjects igf-ir/ir required phospho-igf-ir/ir nt157 binds igf-1r irs-1-igf-ir/ir douglas yee

Questions {❓}

• Yee D (2012) Insulin-like growth factor receptor inhibitors: baby or the bathwater?

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Insulin Receptor Substrate Suppression by the Tyrphostin NT157 Inhibits Responses to Insulin-Like Growth Factor-I and Insulin in Breast Cancer Cells
         description:Insulin and insulin-like growth factor (IGF) signaling systems regulate breast cancer growth, progression, and metastasis. The insulin receptor substrates 1 and 2 (IRS1/2) transduce signaling from the type I IGF receptor (IGF-IR) and insulin receptor (InR) to mediate the biological effects of receptor activation. In breast cancer, IRS-1 plays a critical role in cancer cell proliferation while IRS-2 is associated with motility and metastasis. NT157, a small-molecule tyrphostin, downregulates IRS proteins in several model systems. In breast cancer cells, NT157 treatment suppressed IRS protein expression in a dose-dependent manner. Exposure to NT157 inhibited the activation of downstream signaling mediated by the IRS proteins. NT157 induced a MAPK-dependent serine phosphorylation of IRS proteins which resulted in disassociation between IRS proteins and their receptors resulting in IRS degradation. In estrogen receptor-α-positive (ERα+) breast cancer cells (MCF-7 and T47D), NT157 also resulted in cytoplasmic ERα downregulation likely because of disruption of an IRS-1-IGF-IR/InR/ERα complex. NT157 decreased S phase fraction, monolayer, and anchorage-independent growth after IGF/insulin treatment in ERα+ breast cancer cells. NT157 downregulation of IRS protein expression also sensitized ERα+ breast cancer cells to rapamycin. Moreover, NT157 inhibited the growth of tamoxifen-resistant ERα+ breast cancer cells. Given that both IGF-IR and InR play a role in cancer biology, targeting of IRS adaptor proteins may be a more effective strategy to inhibit the function of these receptors.
         datePublished:2018-09-18T00:00:00Z
         dateModified:2018-09-18T00:00:00Z
         pageStart:371
         pageEnd:382
         sameAs:https://doi.org/10.1007/s12672-018-0343-8
         keywords:
            Inhibits Insulin Receptor Substrate-1
            Nt Treatment
            Serine Phosphorylation
            Anaplastic Lymphoma Receptor Tyrosine Kinase
            Multiple Breast Cancer Cell Lines
            Oncology
            Cancer Research
            Surgical Oncology
            Molecular Medicine
            Radiotherapy
            Internal Medicine
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs12672-018-0343-8/MediaObjects/12672_2018_343_Fig1_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs12672-018-0343-8/MediaObjects/12672_2018_343_Fig2_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs12672-018-0343-8/MediaObjects/12672_2018_343_Fig3_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs12672-018-0343-8/MediaObjects/12672_2018_343_Fig4_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs12672-018-0343-8/MediaObjects/12672_2018_343_Fig5_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs12672-018-0343-8/MediaObjects/12672_2018_343_Fig6_HTML.png
         isPartOf:
            name:Hormones and Cancer
            issn:
               1868-8500
               1868-8497
            volumeNumber:9
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Springer US
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Yuzhe Yang
               affiliation:
                     name:University of Minnesota
                     address:
                        name:Department of Pharmacology, University of Minnesota, Minneapolis, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Jie Ying Chan
               affiliation:
                     name:University of Minnesota
                     address:
                        name:Department of Pharmacology, University of Minnesota, Minneapolis, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Nuri A. Temiz
               affiliation:
                     name:University of Minnesota
                     address:
                        name:Masonic Cancer Center, University of Minnesota, Minneapolis, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Douglas Yee
               url:http://orcid.org/0000-0002-3387-4009
               affiliation:
                     name:University of Minnesota
                     address:
                        name:Department of Pharmacology, University of Minnesota, Minneapolis, USA
                        type:PostalAddress
                     type:Organization
                     name:University of Minnesota
                     address:
                        name:Masonic Cancer Center, University of Minnesota, Minneapolis, USA
                        type:PostalAddress
                     type:Organization
                     name:University of Minnesota
                     address:
                        name:Department of Medicine, University of Minnesota, Minneapolis, USA
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:1
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Insulin Receptor Substrate Suppression by the Tyrphostin NT157 Inhibits Responses to Insulin-Like Growth Factor-I and Insulin in Breast Cancer Cells
      description:Insulin and insulin-like growth factor (IGF) signaling systems regulate breast cancer growth, progression, and metastasis. The insulin receptor substrates 1 and 2 (IRS1/2) transduce signaling from the type I IGF receptor (IGF-IR) and insulin receptor (InR) to mediate the biological effects of receptor activation. In breast cancer, IRS-1 plays a critical role in cancer cell proliferation while IRS-2 is associated with motility and metastasis. NT157, a small-molecule tyrphostin, downregulates IRS proteins in several model systems. In breast cancer cells, NT157 treatment suppressed IRS protein expression in a dose-dependent manner. Exposure to NT157 inhibited the activation of downstream signaling mediated by the IRS proteins. NT157 induced a MAPK-dependent serine phosphorylation of IRS proteins which resulted in disassociation between IRS proteins and their receptors resulting in IRS degradation. In estrogen receptor-α-positive (ERα+) breast cancer cells (MCF-7 and T47D), NT157 also resulted in cytoplasmic ERα downregulation likely because of disruption of an IRS-1-IGF-IR/InR/ERα complex. NT157 decreased S phase fraction, monolayer, and anchorage-independent growth after IGF/insulin treatment in ERα+ breast cancer cells. NT157 downregulation of IRS protein expression also sensitized ERα+ breast cancer cells to rapamycin. Moreover, NT157 inhibited the growth of tamoxifen-resistant ERα+ breast cancer cells. Given that both IGF-IR and InR play a role in cancer biology, targeting of IRS adaptor proteins may be a more effective strategy to inhibit the function of these receptors.
      datePublished:2018-09-18T00:00:00Z
      dateModified:2018-09-18T00:00:00Z
      pageStart:371
      pageEnd:382
      sameAs:https://doi.org/10.1007/s12672-018-0343-8
      keywords:
         Inhibits Insulin Receptor Substrate-1
         Nt Treatment
         Serine Phosphorylation
         Anaplastic Lymphoma Receptor Tyrosine Kinase
         Multiple Breast Cancer Cell Lines
         Oncology
         Cancer Research
         Surgical Oncology
         Molecular Medicine
         Radiotherapy
         Internal Medicine
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs12672-018-0343-8/MediaObjects/12672_2018_343_Fig1_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs12672-018-0343-8/MediaObjects/12672_2018_343_Fig2_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs12672-018-0343-8/MediaObjects/12672_2018_343_Fig3_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs12672-018-0343-8/MediaObjects/12672_2018_343_Fig4_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs12672-018-0343-8/MediaObjects/12672_2018_343_Fig5_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs12672-018-0343-8/MediaObjects/12672_2018_343_Fig6_HTML.png
      isPartOf:
         name:Hormones and Cancer
         issn:
            1868-8500
            1868-8497
         volumeNumber:9
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Springer US
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Yuzhe Yang
            affiliation:
                  name:University of Minnesota
                  address:
                     name:Department of Pharmacology, University of Minnesota, Minneapolis, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Jie Ying Chan
            affiliation:
                  name:University of Minnesota
                  address:
                     name:Department of Pharmacology, University of Minnesota, Minneapolis, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Nuri A. Temiz
            affiliation:
                  name:University of Minnesota
                  address:
                     name:Masonic Cancer Center, University of Minnesota, Minneapolis, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Douglas Yee
            url:http://orcid.org/0000-0002-3387-4009
            affiliation:
                  name:University of Minnesota
                  address:
                     name:Department of Pharmacology, University of Minnesota, Minneapolis, USA
                     type:PostalAddress
                  type:Organization
                  name:University of Minnesota
                  address:
                     name:Masonic Cancer Center, University of Minnesota, Minneapolis, USA
                     type:PostalAddress
                  type:Organization
                  name:University of Minnesota
                  address:
                     name:Department of Medicine, University of Minnesota, Minneapolis, USA
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:1
["Periodical","PublicationVolume"]:
      name:Hormones and Cancer
      issn:
         1868-8500
         1868-8497
      volumeNumber:9
Organization:
      name:Springer US
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:University of Minnesota
      address:
         name:Department of Pharmacology, University of Minnesota, Minneapolis, USA
         type:PostalAddress
      name:University of Minnesota
      address:
         name:Department of Pharmacology, University of Minnesota, Minneapolis, USA
         type:PostalAddress
      name:University of Minnesota
      address:
         name:Masonic Cancer Center, University of Minnesota, Minneapolis, USA
         type:PostalAddress
      name:University of Minnesota
      address:
         name:Department of Pharmacology, University of Minnesota, Minneapolis, USA
         type:PostalAddress
      name:University of Minnesota
      address:
         name:Masonic Cancer Center, University of Minnesota, Minneapolis, USA
         type:PostalAddress
      name:University of Minnesota
      address:
         name:Department of Medicine, University of Minnesota, Minneapolis, USA
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Yuzhe Yang
      affiliation:
            name:University of Minnesota
            address:
               name:Department of Pharmacology, University of Minnesota, Minneapolis, USA
               type:PostalAddress
            type:Organization
      name:Jie Ying Chan
      affiliation:
            name:University of Minnesota
            address:
               name:Department of Pharmacology, University of Minnesota, Minneapolis, USA
               type:PostalAddress
            type:Organization
      name:Nuri A. Temiz
      affiliation:
            name:University of Minnesota
            address:
               name:Masonic Cancer Center, University of Minnesota, Minneapolis, USA
               type:PostalAddress
            type:Organization
      name:Douglas Yee
      url:http://orcid.org/0000-0002-3387-4009
      affiliation:
            name:University of Minnesota
            address:
               name:Department of Pharmacology, University of Minnesota, Minneapolis, USA
               type:PostalAddress
            type:Organization
            name:University of Minnesota
            address:
               name:Masonic Cancer Center, University of Minnesota, Minneapolis, USA
               type:PostalAddress
            type:Organization
            name:University of Minnesota
            address:
               name:Department of Medicine, University of Minnesota, Minneapolis, USA
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:Department of Pharmacology, University of Minnesota, Minneapolis, USA
      name:Department of Pharmacology, University of Minnesota, Minneapolis, USA
      name:Masonic Cancer Center, University of Minnesota, Minneapolis, USA
      name:Department of Pharmacology, University of Minnesota, Minneapolis, USA
      name:Masonic Cancer Center, University of Minnesota, Minneapolis, USA
      name:Department of Medicine, University of Minnesota, Minneapolis, USA

External Links {🔗}(177)

• How much income does https://link.springer.com/privacystatement have?
• Get to know what's the income of https://link.springer.com/article/10.1007/s12672-018-0343-8/#main
• Learn about the earnings of https://link.springer.com
• How profitable is https://idp.springer.com/auth/personal/springernature?redirect_uri=https://link.springer.com/article/10.1007/s12672-018-0343-8?
• See how much https://link.springer.com/article/10.1007/s12672-018-0343-8/#eds-c-header-nav makes per month
• How much profit does https://link.springer.com/journals/ make?
• Financial intake of https://www.springernature.com/gp/authors
• How much cash flow does https://link.springernature.com/home/ have monthly?
• How much income is https://link.springer.com/article/10.1007/s12672-018-0343-8/#eds-c-header-popup-search earning monthly?
• How much does https://order.springer.com/public/cart generate monthly?
• Income figures for https://link.springer.com/article/10.1007/s12672-018-0343-8/
• Explore the financials of https://link.springer.com/article/10.1007/s12672-018-0343-8/journal/12672
• Monthly income for https://link.springer.com/article/10.1007/s12672-018-0343-8/#citeas
• https://link.springer.com/article/10.1007/s12672-018-0343-8/content/pdf/10.1007/s12672-018-0343-8.pdf's total income per month
• What is the earnings of https://link.springer.com/article/10.1007/s12672-018-0343-8/journal/12672/aims-and-scope?
• How much does https://submission.nature.com/new-submission/12672/3 pull in monthly?
• https://link.springer.com/article/10.1007/s12672-018-0343-8/#auth-Yuzhe-Yang-Aff1's revenue stream
• https://link.springer.com/article/10.1007/s12672-018-0343-8/#Aff1's financial summary
• How much does https://link.springer.com/article/10.1007/s12672-018-0343-8/#auth-Jie_Ying-Chan-Aff1 rake in every month?
• Revenue of https://link.springer.com/article/10.1007/s12672-018-0343-8/#auth-Nuri_A_-Temiz-Aff2
• How much profit does https://link.springer.com/article/10.1007/s12672-018-0343-8/#Aff2 make?
• What's the income of https://link.springer.com/article/10.1007/s12672-018-0343-8/#auth-Douglas-Yee-Aff1-Aff2-Aff3?
• What's the monthly income of https://orcid.org/0000-0002-3387-4009?
• How much money does https://link.springer.com/article/10.1007/s12672-018-0343-8/#Aff3 generate?
• How much does https://link.springer.com/article/10.1007/s12672-018-0343-8/article/10.1007/s12672-018-0343-8/metrics pull in monthly?
• How much does https://link.springer.com/10.1038/onc.2015.488?fromPaywallRec=false pull in?
• How much profit is https://link.springer.com/10.1038/ncomms13567?fromPaywallRec=false making per month?
• Get to know what's the income of https://link.springer.com/10.1007/s12282-018-0922-0?fromPaywallRec=false
• Explore the financials of https://link.springer.com/article/10.1007/s12672-018-0343-8/subjects/endocrine-cancer
• How much does https://link.springer.com/article/10.1007/s12672-018-0343-8/subjects/er-associated-degradation net monthly?
• What's the total monthly financial gain of https://link.springer.com/article/10.1007/s12672-018-0343-8/subjects/growth-factor-signalling?
• What's the monthly income of https://link.springer.com/article/10.1007/s12672-018-0343-8/subjects/hormone-receptors?
• Explore the financials of https://link.springer.com/article/10.1007/s12672-018-0343-8/subjects/insulin-signalling
• What's the income of https://link.springer.com/article/10.1007/s12672-018-0343-8/subjects/tumour-suppressor-proteins?
• Profit of https://beta.springernature.com/pre-submission?journalId=12672
• How much revenue does https://link.springer.com/article/10.1007/s12672-018-0343-8/article/10.1007/s12672-018-0343-8#ref-CR1 bring in?
• How much profit is https://link.springer.com/article/10.1007/s12672-018-0343-8/article/10.1007/s12672-018-0343-8#ref-CR2 making per month?
• How much does https://link.springer.com/article/10.1007/s12672-018-0343-8/article/10.1007/s12672-018-0343-8#ref-CR3 generate monthly?
• Find out how much https://link.springer.com/article/10.1007/s12672-018-0343-8/article/10.1007/s12672-018-0343-8#ref-CR4 earns monthly
• What's the income generated by https://link.springer.com/article/10.1007/s12672-018-0343-8/article/10.1007/s12672-018-0343-8#ref-CR5 each month?
• See how much https://link.springer.com/article/10.1007/s12672-018-0343-8/article/10.1007/s12672-018-0343-8#ref-CR6 makes per month
• How much revenue does https://link.springer.com/article/10.1007/s12672-018-0343-8/article/10.1007/s12672-018-0343-8#ref-CR7 produce monthly?
• How profitable is https://link.springer.com/article/10.1007/s12672-018-0343-8/article/10.1007/s12672-018-0343-8#ref-CR8?
• How much does https://link.springer.com/article/10.1007/s12672-018-0343-8/article/10.1007/s12672-018-0343-8#ref-CR9 generate monthly?
• Earnings of https://link.springer.com/article/10.1007/s12672-018-0343-8/article/10.1007/s12672-018-0343-8#ref-CR10
• What's the monthly money flow for https://link.springer.com/article/10.1007/s12672-018-0343-8/article/10.1007/s12672-018-0343-8#ref-CR11?
• How much does https://link.springer.com/article/10.1007/s12672-018-0343-8/article/10.1007/s12672-018-0343-8#ref-CR12 make?
• http://www.oncomine.org's total income per month
• How much money does https://link.springer.com/article/10.1007/s12672-018-0343-8/article/10.1007/s12672-018-0343-8#ref-CR13 generate?
• How much money does https://link.springer.com/article/10.1007/s12672-018-0343-8/article/10.1007/s12672-018-0343-8#Fig1 generate?
• Get to know what's the income of https://link.springer.com/article/10.1007/s12672-018-0343-8/article/10.1007/s12672-018-0343-8#MOESM1
• How much profit does https://link.springer.com/article/10.1007/s12672-018-0343-8/article/10.1007/s12672-018-0343-8/figures/1 generate?
• What's the income of https://link.springer.com/article/10.1007/s12672-018-0343-8/article/10.1007/s12672-018-0343-8#ref-CR14?
• How much does https://link.springer.com/article/10.1007/s12672-018-0343-8/article/10.1007/s12672-018-0343-8#ref-CR15 net monthly?
• How much does https://link.springer.com/article/10.1007/s12672-018-0343-8/article/10.1007/s12672-018-0343-8#Fig2 gross monthly?
• What are the earnings of https://link.springer.com/article/10.1007/s12672-018-0343-8/article/10.1007/s12672-018-0343-8#ref-CR16?
• What's the total monthly financial gain of https://link.springer.com/article/10.1007/s12672-018-0343-8/article/10.1007/s12672-018-0343-8#ref-CR17?
• What's the profit of https://link.springer.com/article/10.1007/s12672-018-0343-8/article/10.1007/s12672-018-0343-8/figures/2?
• How much profit does https://link.springer.com/article/10.1007/s12672-018-0343-8/article/10.1007/s12672-018-0343-8#ref-CR18 generate?
• Financial intake of https://link.springer.com/article/10.1007/s12672-018-0343-8/article/10.1007/s12672-018-0343-8#Fig3
• How much does https://link.springer.com/article/10.1007/s12672-018-0343-8/article/10.1007/s12672-018-0343-8/figures/3 make?
• What's the financial outcome of https://link.springer.com/article/10.1007/s12672-018-0343-8/article/10.1007/s12672-018-0343-8#Fig4?
• What is the earnings of https://link.springer.com/article/10.1007/s12672-018-0343-8/article/10.1007/s12672-018-0343-8/figures/4?
• How much does https://link.springer.com/article/10.1007/s12672-018-0343-8/article/10.1007/s12672-018-0343-8#Fig5 earn?
• Financial intake of https://link.springer.com/article/10.1007/s12672-018-0343-8/article/10.1007/s12672-018-0343-8/figures/5
• https://link.springer.com/article/10.1007/s12672-018-0343-8/article/10.1007/s12672-018-0343-8#ref-CR19's total income per month
• Monthly income for https://link.springer.com/article/10.1007/s12672-018-0343-8/article/10.1007/s12672-018-0343-8#ref-CR20
• What's the monthly income of https://link.springer.com/article/10.1007/s12672-018-0343-8/article/10.1007/s12672-018-0343-8#ref-CR21?
• How much income is https://link.springer.com/article/10.1007/s12672-018-0343-8/article/10.1007/s12672-018-0343-8#ref-CR22 earning monthly?
• How much income is https://link.springer.com/article/10.1007/s12672-018-0343-8/article/10.1007/s12672-018-0343-8#ref-CR23 earning monthly?
• What's the income of https://link.springer.com/article/10.1007/s12672-018-0343-8/article/10.1007/s12672-018-0343-8#Fig6?
• Income figures for https://link.springer.com/article/10.1007/s12672-018-0343-8/article/10.1007/s12672-018-0343-8/figures/6
• What are the earnings of https://link.springer.com/article/10.1007/s12672-018-0343-8/article/10.1007/s12672-018-0343-8#ref-CR24?
• What's the profit of https://link.springer.com/article/10.1007/s12672-018-0343-8/article/10.1007/s12672-018-0343-8#ref-CR25?
• Discover the revenue of https://link.springer.com/article/10.1007/s12672-018-0343-8/article/10.1007/s12672-018-0343-8#ref-CR26
• How much does https://link.springer.com/article/10.1007/s12672-018-0343-8/article/10.1007/s12672-018-0343-8#ref-CR27 rake in every month?
• See how much https://link.springer.com/article/10.1007/s12672-018-0343-8/articles/cas-redirect/1:CAS:528:DC%2BC38Xit12jsrs%3D makes per month
• Profit of http://scholar.google.com/scholar_lookup?&title=The%20insulin%20and%20insulin-like%20growth%20factor%20receptor%20family%20in%20neoplasia%3A%20an%20update&journal=Nat%20Rev%20Cancer&doi=10.1038%2Fnrc3215&volume=12&pages=159-169&publication_year=2012&author=Pollak%2CM
• How profitable is https://link.springer.com/doi/10.1007/s10911-012-9268-y?
• How much profit does http://scholar.google.com/scholar_lookup?&title=Targeting%20insulin%20and%20insulin-like%20growth%20factor%20signaling%20in%20breast%20cancer&journal=J%20Mammary%20Gland%20Biol%20Neoplasia&doi=10.1007%2Fs10911-012-9268-y&volume=17&pages=251-261&publication_year=2012&author=Yang%2CY&author=Yee%2CD generate?
• What's the financial gain of https://link.springer.com/article/10.1007/s12672-018-0343-8/articles/cas-redirect/1:CAS:528:DC%2BD28XhtFChs7zN?
• What's the income of http://scholar.google.com/scholar_lookup?&title=Insulin%20receptor%20substrates%20mediate%20distinct%20biological%20responses%20to%20insulin-like%20growth%20factor%20receptor%20activation%20in%20breast%20cancer%20cells&journal=Br%20J%20Cancer&doi=10.1038%2Fsj.bjc.6603354&volume=95&pages=1220-1228&publication_year=2006&author=Byron%2CSA&author=Horwitz%2CKB&author=Richer%2CJK&author=Lange%2CCA&author=Zhang%2CX&author=Yee%2CD?
• How much cash flow does https://link.springer.com/article/10.1007/s12672-018-0343-8/articles/cas-redirect/1:CAS:528:DyaK1cXivVOrsLs%3D have monthly?
• Discover the revenue of http://scholar.google.com/scholar_lookup?&title=Insulin%20receptor%20substrate-1%20is%20the%20predominant%20signaling%20molecule%20activated%20by%20insulin-like%20growth%20factor-i%2C%20insulin%2C%20and%20interleukin-4%20in%20estrogen%20receptor-positive%20human%20breast%20cancer%20cells&journal=J%20Biol%20Chem&doi=10.1074%2Fjbc.273.16.9994&volume=273&pages=9994-10003&publication_year=1998&author=Jackson%2CJG&author=White%2CMF&author=Yee%2CD
• How much income does https://link.springer.com/article/10.1007/s12672-018-0343-8/articles/cas-redirect/1:CAS:528:DC%2BD3MXovVOntL0%3D have?
• What's http://scholar.google.com/scholar_lookup?&title=Regulation%20of%20breast%20cancer%20cell%20motility%20by%20insulin%20receptor%20substrate-2%20%28irs-2%29%20in%20metastatic%20variants%20of%20human%20breast%20cancer%20cell%20lines&journal=Oncogene&doi=10.1038%2Fsj.onc.1204920&volume=20&pages=7318-7325&publication_year=2001&author=Jackson%2CJG&author=Zhang%2CX&author=Yoneda%2CT&author=Yee%2CD's gross income?
• How much income is https://link.springer.com/article/10.1007/s12672-018-0343-8/articles/cas-redirect/1:CAS:528:DC%2BC2sXns1amur8%3D earning monthly?
• What's the monthly income of http://scholar.google.com/scholar_lookup?&title=Differential%20involvement%20of%20the%20microtubule%20cytoskeleton%20in%20insulin%20receptor%20substrate%201%20%28irs-1%29%20and%20irs-2%20signaling%20to%20akt%20determines%20the%20response%20to%20microtubule%20disruption%20in%20breast%20carcinoma%20cells&journal=J%20Biol%20Chem&doi=10.1074%2Fjbc.M117.785832&volume=292&pages=7806-7816&publication_year=2017&author=Mercado-Matos%2CJ&author=Clark%2CJL&author=Piper%2CAJ&author=Janusis%2CJ&author=Shaw%2CLM?
• https://link.springer.com/article/10.1007/s12672-018-0343-8/articles/cas-redirect/1:CAS:528:DC%2BC2MXislGhtL4%3D's total income per month
• How much does http://scholar.google.com/scholar_lookup?&title=A%20tale%20of%20two%20receptors%3A%20insulin%20and%20insulin-like%20growth%20factor%20signaling%20in%20cancer&journal=Clin%20Cancer%20Res&doi=10.1158%2F1078-0432.CCR-14-2056&volume=21&pages=667-669&publication_year=2015&author=Yee%2CD pull in?
• What is the monthly revenue of https://link.springer.com/article/10.1007/s12672-018-0343-8/articles/cas-redirect/1:CAS:528:DC%2BC28XhtlKmurw%3D?
• Get to know what's the income of http://scholar.google.com/scholar_lookup?&title=Clinical%20and%20translational%20results%20of%20a%20phase%20ii%2C%20randomized%20trial%20of%20an%20anti-igf-1r%20%28cixutumumab%29%20in%20women%20with%20breast%20cancer%20that%20progressed%20on%20endocrine%20therapy&journal=Clin%20Cancer%20Res&doi=10.1158%2F1078-0432.CCR-15-0588&volume=22&pages=301-309&publication_year=2016&author=Gradishar%2CWJ&author=Yardley%2CDA&author=Layman%2CR&author=Sparano%2CJA&author=Chuang%2CE&author=Northfelt%2CDW&author=Schwartz%2CGN&author=Youssoufian%2CH&author=Tang%2CS&author=Novosiadly%2CR&author=Forest%2CA&author=Nguyen%2CTS&author=Cosaert%2CJ&author=Grebennik%2CD&author=Haluska%2CP
• What's the revenue for https://link.springer.com/article/10.1007/s12672-018-0343-8/articles/cas-redirect/1:CAS:528:DC%2BC3sXhtFSrtrnJ?
• What's the financial gain of http://scholar.google.com/scholar_lookup?&title=Therapeutic%20destruction%20of%20insulin%20receptor%20substrates%20for%20cancer%20treatment&journal=Cancer%20Res&doi=10.1158%2F0008-5472.CAN-12-3385&volume=73&pages=4383-4394&publication_year=2013&author=Reuveni%2CH&author=Flashner-Abramson%2CE&author=Steiner%2CL&author=Makedonski%2CK&author=Song%2CR&author=Shir%2CA&author=Herlyn%2CM&author=Bar-Eli%2CM&author=Levitzki%2CA?
• How much revenue does https://link.springer.com/article/10.1007/s12672-018-0343-8/articles/cas-redirect/1:CAS:528:DC%2BC2cXitVCju7vO bring in?
• http://scholar.google.com/scholar_lookup?&title=The%20tyrphostin%20nt157%20suppresses%20insulin%20receptor%20substrates%20and%20augments%20therapeutic%20response%20of%20prostate%20cancer&journal=Mol%20Cancer%20Ther&doi=10.1158%2F1535-7163.MCT-13-0842&volume=13&pages=2827-2839&publication_year=2014&author=Ibuki%2CN&author=Ghaffari%2CM&author=Reuveni%2CH&author=Pandey%2CM&author=Fazli%2CL&author=Azuma%2CH&author=Gleave%2CME&author=Levitzki%2CA&author=Cox%2CME income
• What's the profit of https://link.springer.com/article/10.1007/s12672-018-0343-8/articles/cas-redirect/1:CAS:528:DC%2BC1cXosF2qsbo%3D?
• Learn about the earnings of http://scholar.google.com/scholar_lookup?&title=Impact%20of%20the%20anticancer%20drug%20nt157%20on%20tyrosine%20kinase%20signaling%20networks&journal=Mol%20Cancer%20Ther&doi=10.1158%2F1535-7163.MCT-17-0377&volume=17&pages=931-942&publication_year=2018&author=Su%2CSP&author=Flashner-Abramson%2CE&author=Klein%2CS&author=Gal%2CM&author=Lee%2CRS&author=Wu%2CJ&author=Levitzki%2CA&author=Daly%2CRJ
• What's the profit of https://link.springer.com/article/10.1007/s12672-018-0343-8/articles/cas-redirect/1:CAS:528:DC%2BC38XpsFKrsro%3D?
• How much income is http://scholar.google.com/scholar_lookup?&title=Acquired%20resistance%20to%20tamoxifen%20is%20associated%20with%20loss%20of%20the%20type%20I%20insulin-like%20growth%20factor%20receptor%3A%20implications%20for%20breast%20cancer%20treatment&journal=Cancer%20Res&doi=10.1158%2F0008-5472.CAN-12-0684&volume=72&pages=3372-3380&publication_year=2012&author=Fagan%2CDH&author=Uselman%2CRR&author=Sachdev%2CD&author=Yee%2CD earning monthly?
• https://link.springer.com/doi/10.1007/s10549-009-0674-9's financial summary
• Learn how profitable http://scholar.google.com/scholar_lookup?&title=An%20online%20survival%20analysis%20tool%20to%20rapidly%20assess%20the%20effect%20of%2022%2C277%20genes%20on%20breast%20cancer%20prognosis%20using%20microarray%20data%20of%201%2C809%20patients&journal=Breast%20Cancer%20Res%20Treat&doi=10.1007%2Fs10549-009-0674-9&volume=123&pages=725-731&publication_year=2010&author=Gyorffy%2CB&author=Lanczky%2CA&author=Eklund%2CAC&author=Denkert%2CC&author=Budczies%2CJ&author=Li%2CQ&author=Szallasi%2CZ is on a monthly basis
• https://link.springer.com/article/10.1007/s12672-018-0343-8/articles/cas-redirect/1:CAS:528:DC%2BD3MXlvVCgtbw%3D's financial summary
• What is the earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=11479214?
• What's the revenue for http://scholar.google.com/scholar_lookup?&title=Re-expression%20of%20estrogen%20receptor%20alpha%20in%20estrogen%20receptor%20alpha-%20negative%20mcf-7%20cells%20restores%20both%20estrogen%20and%20insulin-like%20growth%20factor-mediated%20signaling%20and%20growth&journal=Cancer%20Res&volume=61&pages=5771-5777&publication_year=2001&author=Oesterreich%2CS&author=Zhang%2CP&author=Guler%2CRL&author=Sun%2CX&author=Curran%2CEM&author=Welshons%2CWV&author=Osborne%2CCK&author=Lee%2CAV?
• Get to know what's the income of https://link.springer.com/article/10.1007/s12672-018-0343-8/articles/cas-redirect/1:CAS:528:DC%2BC38XkvFClug%3D%3D
• Earnings of http://scholar.google.com/scholar_lookup?&title=Developmental%20stage%20determines%20estrogen%20receptor%20alpha%20expression%20and%20non-genomic%20mechanisms%20that%20control%20igf-1%20signaling%20and%20mammary%20proliferation%20in%20mice&journal=J%20Clin%20Invest&doi=10.1172%2FJCI42204&volume=122&pages=192-204&publication_year=2012&author=Tian%2CJ&author=Berton%2CTR&author=Shirley%2CSH&author=Lambertz%2CI&author=Gimenez-Conti%2CIB&author=DiGiovanni%2CJ&author=Korach%2CKS&author=Conti%2CCJ&author=Fuchs-Young%2CR
• Get to know what's the income of https://link.springer.com/article/10.1007/s12672-018-0343-8/articles/cas-redirect/1:CAS:528:DyaK1MXivVyktL0%3D
• Learn how profitable http://scholar.google.com/scholar_lookup?&title=Enhancement%20of%20insulin-like%20growth%20factor%20signaling%20in%20human%20breast%20cancer%3A%20estrogen%20regulation%20of%20insulin%20receptor%20substrate-1%20expression%20in%20vitro%20and%20in%20vivo&journal=Mol%20Endocrinol&doi=10.1210%2Fmend.13.5.0274&volume=13&pages=787-796&publication_year=1999&author=Lee%2CAV&author=Jackson%2CJG&author=Gooch%2CJL&author=Hilsenbeck%2CSG&author=Coronado-Heinsohn%2CE&author=Osborne%2CCK&author=Yee%2CD is on a monthly basis
• How much cash flow does https://link.springer.com/article/10.1007/s12672-018-0343-8/articles/cas-redirect/1:CAS:528:DC%2BD3cXjtVart78%3D have monthly?
• What is the earnings of http://scholar.google.com/scholar_lookup?&title=Insulin%20receptor%20substrate-1%20expression%20is%20regulated%20by%20estrogen%20in%20the%20mcf-7%20human%20breast%20cancer%20cell%20line&journal=J%20Biol%20Chem&doi=10.1074%2Fjbc.275.17.12565&volume=275&pages=12565-12571&publication_year=2000&author=Molloy%2CCA&author=May%2CFE&author=Westley%2CBR?
• How much does https://link.springer.com/article/10.1007/s12672-018-0343-8/articles/cas-redirect/1:CAS:528:DC%2BC3cXitlSltLc%3D pull in?
• Profit of http://scholar.google.com/scholar_lookup?&title=Estrogen%20utilization%20of%20igf-1-r%20and%20egf-r%20to%20signal%20in%20breast%20cancer%20cells&journal=J%20Steroid%20Biochem%20Mol%20Biol&doi=10.1016%2Fj.jsbmb.2009.09.018&volume=118&pages=219-230&publication_year=2010&author=Song%2CRX&author=Chen%2CY&author=Zhang%2CZ&author=Bao%2CY&author=Yue%2CW&author=Wang%2CJP&author=Fan%2CP&author=Santen%2CRJ
• Profit of https://link.springer.com/article/10.1007/s12672-018-0343-8/articles/cas-redirect/1:CAS:528:DC%2BC2cXmtVOmt74%3D
• How much money does http://scholar.google.com/scholar_lookup?&title=Igf-I%20regulates%20redox%20status%20in%20breast%20cancer%20cells%20by%20activating%20the%20amino%20acid%20transport%20molecule%20xC&journal=Cancer%20Res&doi=10.1158%2F0008-5472.CAN-13-1803&volume=74&pages=2295-2305&publication_year=2014&author=Yang%2CY&author=Yee%2CD make?
• How profitable is https://link.springer.com/article/10.1007/s12672-018-0343-8/articles/cas-redirect/1:CAS:528:DC%2BC3MXksFaiu74%3D?
• Discover the revenue of http://scholar.google.com/scholar_lookup?&title=Next-generation%20mtor%20inhibitors%20in%20clinical%20oncology%3A%20how%20pathway%20complexity%20informs%20therapeutic%20strategy&journal=J%20Clin%20Invest&doi=10.1172%2FJCI44145&volume=121&pages=1231-1241&publication_year=2011&author=Wander%2CSA&author=Hennessy%2CBT&author=Slingerland%2CJM
• Find out how much https://link.springer.com/article/10.1007/s12672-018-0343-8/articles/cas-redirect/1:STN:280:DC%2BD2M7kvVWmsQ%3D%3D earns monthly
• How much profit does http://scholar.google.com/scholar_lookup?&title=Mtor-targeted%20therapy%20of%20cancer%20with%20rapamycin%20derivatives&journal=Ann%20Oncol&doi=10.1093%2Fannonc%2Fmdi113&volume=16&pages=525-537&publication_year=2005&author=Vignot%2CS&author=Faivre%2CS&author=Aguirre%2CD&author=Raymond%2CE generate?
• Find out how much https://link.springer.com/article/10.1007/s12672-018-0343-8/articles/cas-redirect/1:CAS:528:DC%2BD2sXhtVWisrvL earns monthly
• What's the monthly money flow for http://scholar.google.com/scholar_lookup?&title=Identification%20of%20irs-1%20ser-1101%20as%20a%20target%20of%20s6k1%20in%20nutrient-%20and%20obesity-induced%20insulin%20resistance&journal=Proc%20Natl%20Acad%20Sci%20U%20S%20A&doi=10.1073%2Fpnas.0706517104&volume=104&pages=14056-14061&publication_year=2007&author=Tremblay%2CF&author=Brule%2CS&author=Hee%20Um%2CS&author=Li%2CY&author=Masuda%2CK&author=Roden%2CM&author=Sun%2CXJ&author=Krebs%2CM&author=Polakiewicz%2CRD&author=Thomas%2CG&author=Marette%2CA?
• http://scholar.google.com/scholar_lookup?&title=mTOR%20inhibition%20induces%20upstream%20receptor%20tyrosine%20kinase%20signaling%20and%20activates%20Akt&journal=Cancer%20Res&doi=10.1158%2F0008-5472.CAN-05-2925&volume=66&pages=1500-1508&publication_year=2006&author=O%E2%80%99Reilly%2CKE&author=Rojo%2CF&author=She%2CQB&author=Solit%2CD&author=Mills%2CGB&author=Smith%2CD&author=Lane%2CH&author=Hofmann%2CF&author=Hicklin%2CDJ&author=Ludwig%2CDL&author=Baselga%2CJ&author=Rosen%2CN's total income per month
• How much does https://link.springer.com/article/10.1007/s12672-018-0343-8/articles/cas-redirect/1:CAS:528:DC%2BC38XhtVOjsLrM generate monthly?
• How much income is http://scholar.google.com/scholar_lookup?&title=Insulin-like%20growth%20factor%20receptor%20inhibitors%3A%20baby%20or%20the%20bathwater%3F&journal=J%20Natl%20Cancer%20Inst&doi=10.1093%2Fjnci%2Fdjs258&volume=104&pages=975-981&publication_year=2012&author=Yee%2CD earning monthly?
• Find out how much https://link.springer.com/article/10.1007/s12672-018-0343-8/articles/cas-redirect/1:CAS:528:DC%2BD1MXhsFyrurvN earns monthly
• How much revenue does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=20182580 produce monthly?
• How much revenue does http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2826820 bring in?
• What's the profit of http://scholar.google.com/scholar_lookup?&title=Physiological%20regulation%20of%20Akt%20activity%20and%20stability&journal=Am%20J%20Transl%20Res&volume=2&pages=19-42&publication_year=2010&author=Liao%2CY&author=Hung%2CMC?
• How much profit does https://link.springer.com/article/10.1007/s12672-018-0343-8/articles/cas-redirect/1:CAS:528:DC%2BC2cXhsVCrtb7F generate?
• How much profit is http://scholar.google.com/scholar_lookup?&title=Rationale%20for%20co-targeting%20IGF-1R%20and%20ALK%20in%20ALK%20fusion-positive%20lung%20cancer&journal=Nat%20Med&doi=10.1038%2Fnm.3667&volume=20&pages=1027-1034&publication_year=2014&author=Lovly%2CCM&author=McDonald%2CNT&author=Chen%2CH&author=Ortiz-Cuaran%2CS&author=Heukamp%2CLC&author=Yan%2CY&author=Florin%2CA&author=Ozretic%2CL&author=Lim%2CD&author=Wang%2CL&author=Chen%2CZ&author=Chen%2CX&author=Lu%2CP&author=Paik%2CPK&author=Shen%2CR&author=Jin%2CH&author=Buettner%2CR&author=Ansen%2CS&author=Perner%2CS&author=Brockmann%2CM&author=Bos%2CM&author=Wolf%2CJ&author=Gardizi%2CM&author=Wright%2CGM&author=Solomon%2CB&author=Russell%2CPA&author=Rogers%2CTM&author=Suehara%2CY&author=Red-Brewer%2CM&author=Tieu%2CR&author=Stanchina%2CE&author=Wang%2CQ&author=Zhao%2CZ&author=Johnson%2CDH&author=Horn%2CL&author=Wong%2CKK&author=Thomas%2CRK&author=Ladanyi%2CM&author=Pao%2CW making per month?
• What are the earnings of http://scholar.google.com/scholar_lookup?&title=Pi3k%20inhibition%20results%20in%20enhanced%20estrogen%20receptor%20function%20and%20dependence%20in%20hormone%20receptor-positive%20breast%20cancer&journal=Sci%20Transl%20Med&doi=10.1126%2Fscitranslmed.aaa4442&volume=7&publication_year=2015&author=Bosch%2CA&author=Li%2CZ&author=Bergamaschi%2CA&author=Ellis%2CH&author=Toska%2CE&author=Prat%2CA&author=Tao%2CJJ&author=Spratt%2CDE&author=Viola-Villegas%2CNT&author=Castel%2CP&author=Minuesa%2CG&author=Morse%2CN&author=Rodon%2CJ&author=Ibrahim%2CY&author=Cortes%2CJ&author=Perez-Garcia%2CJ&author=Galvan%2CP&author=Grueso%2CJ&author=Guzman%2CM&author=Katzenellenbogen%2CJA&author=Kharas%2CM&author=Lewis%2CJS&author=Dickler%2CM&author=Serra%2CV&author=Rosen%2CN&author=Chandarlapaty%2CS&author=Scaltriti%2CM&author=Baselga%2CJ?
• Revenue of https://citation-needed.springer.com/v2/references/10.1007/s12672-018-0343-8?format=refman&flavour=references
• Find out how much https://link.springer.com/article/10.1007/s12672-018-0343-8/search?sortBy=newestFirst&dc.creator=Yuzhe%20Yang earns monthly
• How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Yuzhe%20Yang pull in monthly?
• How profitable is https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Yuzhe%20Yang%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
• https://link.springer.com/article/10.1007/s12672-018-0343-8/search?sortBy=newestFirst&dc.creator=Jie%20Ying%20Chan's financial summary
• How profitable is https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Jie%20Ying%20Chan?
• What's https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Jie%20Ying%20Chan%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en's gross income?
• What is the monthly revenue of https://link.springer.com/article/10.1007/s12672-018-0343-8/search?sortBy=newestFirst&dc.creator=Nuri%20A.%20Temiz?
• How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Nuri%20A.%20Temiz gross monthly?
• How much profit does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Nuri%20A.%20Temiz%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en generate?
• How much does https://link.springer.com/article/10.1007/s12672-018-0343-8/search?sortBy=newestFirst&dc.creator=Douglas%20Yee pull in?
• What's https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Douglas%20Yee's gross income?
• How much profit does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Douglas%20Yee%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en generate?
• Discover the revenue of https://link.springer.com/article/10.1007/s12672-018-0343-8/mailto:[email protected]
• What are the total earnings of https://static-content.springer.com/esm/art%3A10.1007%2Fs12672-018-0343-8/MediaObjects/12672_2018_343_MOESM1_ESM.pptx?
• Get to know what's the income of https://s100.copyright.com/AppDispatchServlet?title=Insulin%20Receptor%20Substrate%20Suppression%20by%20the%20Tyrphostin%20NT157%20Inhibits%20Responses%20to%20Insulin-Like%20Growth%20Factor-I%20and%20Insulin%20in%20Breast%20Cancer%20Cells&author=Yuzhe%20Yang%20et%20al&contentID=10.1007%2Fs12672-018-0343-8©right=Springer%20Science%2BBusiness%20Media%2C%20LLC%2C%20part%20of%20Springer%20Nature&publication=1868-8497&publicationDate=2018-09-18&publisherName=SpringerNature&orderBeanReset=true
• Get to know https://crossmark.crossref.org/dialog/?doi=10.1007/s12672-018-0343-8's earnings
• What's the financial outcome of https://citation-needed.springer.com/v2/references/10.1007/s12672-018-0343-8?format=refman&flavour=citation?
• Check the income stats for https://link.springer.com/article/10.1007/s12672-018-0343-8/search?query=Inhibits%20Insulin%20Receptor%20Substrate-1&facet-discipline="Medicine%20%26%20Public%20Health"
• What's https://link.springer.com/article/10.1007/s12672-018-0343-8/search?query=Nt%20Treatment&facet-discipline="Medicine%20%26%20Public%20Health"'s gross income?
• See how much https://link.springer.com/article/10.1007/s12672-018-0343-8/search?query=Serine%20Phosphorylation&facet-discipline="Medicine%20%26%20Public%20Health" makes per month
• How much does https://link.springer.com/article/10.1007/s12672-018-0343-8/search?query=Anaplastic%20Lymphoma%20Receptor%20Tyrosine%20Kinase&facet-discipline="Medicine%20%26%20Public%20Health" rake in every month?
• What is the monthly revenue of https://link.springer.com/article/10.1007/s12672-018-0343-8/search?query=Multiple%20Breast%20Cancer%20Cell%20Lines&facet-discipline="Medicine%20%26%20Public%20Health"?
• Learn about the earnings of https://link.springer.com/article/10.1007/s12672-018-0343-8/researchers/22283178SN
• Income figures for https://link.springer.com/journals/a/1
• What's https://link.springer.com/books/a/1's gross income?
• What's the income generated by https://link.springer.com/journals each month?
• How much profit does https://authorservices.springernature.com/go/sn/?utm_source=SNLinkfooter&utm_medium=Web&utm_campaign=SNReferral make?
• Earnings of https://www.springernature.com/gp/open-research/about/the-fundamentals-of-open-access-and-open-research
• How profitable is https://www.springernature.com/gp/products?
• https://www.springernature.com/gp/librarians's financial summary
• What's the monthly money flow for https://www.springernature.com/gp/societies?
• How much does https://www.springernature.com/gp/partners bring in each month?
• https://www.springer.com/ income
• Check the income stats for https://www.nature.com/
• How much income is https://www.biomedcentral.com/ earning monthly?
• Income figures for https://www.palgrave.com/
• https://www.apress.com/ income
• https://link.springer.com/brands/discover's financial summary
• https://www.springernature.com/gp/legal/ccpa's revenue stream
• How much does https://www.springernature.com/gp/info/accessibility rake in every month?
• https://link.springer.com/termsandconditions income
• What's the income of https://support.springernature.com/en/support/home?
• What is the earnings of https://link.springer.com/legal-notice?
• How much does https://support.springernature.com/en/support/solutions/articles/6000255911-subscription-cancellations gross monthly?
• Find out how much https://www.springernature.com/ earns monthly

Analytics and Tracking {📊}

• Google Tag Manager

Libraries {📚}

• Clipboard.js
• Prism.js

Emails and Hosting {✉️}

Mail Servers:

• mx.zoho.eu
• mx2.zoho.eu
• mx3.zoho.eu

Name Servers:

• josh.ns.cloudflare.com
• zita.ns.cloudflare.com

CDN Services {📦}

• Crossref